Encompass Health Corporation Payments to Acquire Restricted Investments
Encompass Health Corporation (EHC) reported Payments to Acquire Restricted Investments of $54.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRestrictedInvestments · last filed 2026-08-07
- Encompass Health Corporation payments to acquire restricted investments for the quarter ending 2026-06-30 was $28.10M, a 77.61% decline year-over-year.
- Encompass Health Corporation payments to acquire restricted investments for the quarter ending 2026-03-31 was $26.40M, a 1047.83% increase year-over-year.
- Encompass Health Corporation payments to acquire restricted investments for the quarter ending 2025-12-31 was $18.50M, a 640.00% increase year-over-year.
- Encompass Health Corporation payments to acquire restricted investments for the quarter ending 2025-09-30 was $38.10M, a 222.88% increase year-over-year.
- Encompass Health Corporation payments to acquire restricted investments for fiscal 2025 was $184.40M, a 719.56% increase from fiscal 2024.
- Encompass Health Corporation payments to acquire restricted investments for fiscal 2024 was $22.50M, a 2.17% decline from fiscal 2023.
- Encompass Health Corporation payments to acquire restricted investments for fiscal 2023 was $23.00M, a 34.66% decline from fiscal 2022.
- Encompass Health Corporation payments to acquire restricted investments for fiscal 2022 was $35.20M, a 291.11% increase from fiscal 2021.
| Period end | Payments to Acquire Restricted Investments 3 month | Payments to Acquire Restricted Investments 6 month | Payments to Acquire Restricted Investments 9 month | Payments to Acquire Restricted Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $54.50M 10-Q · filed 2026-08-07 | $73.00M derived: sum of 3 quarters · filed 2026-08-07 | $111.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $26.40M 10-Q · filed 2026-05-01 | $44.90M derived: sum of 2 quarters · filed 2026-05-01 | $83.00M derived: sum of 3 quarters · filed 2026-05-01 | $208.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $56.60M derived: sum of 2 quarters · filed 2026-02-26 | $182.10M derived: sum of 3 quarters · filed 2026-08-07 | $184.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $163.60M derived: sum of 2 quarters · filed 2026-08-07 | $165.90M 10-Q · filed 2025-10-31 | $168.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $125.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $127.80M 10-Q · filed 2026-08-07 | $130.30M derived: sum of 3 quarters · filed 2026-08-07 | $142.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-01 | $4.80M derived: sum of 2 quarters · filed 2026-05-01 | $16.60M derived: sum of 3 quarters · filed 2026-05-01 | |
| 2024-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.30M derived: sum of 2 quarters · filed 2026-02-26 | $22.50M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $11.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $20.00M 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | $8.20M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.00M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $21.10M 10-Q · filed 2024-11-01 | |||
| 2022-12-31 | $10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $35.20M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $25.10M 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $9.00M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $8.30M 10-Q · filed 2022-11-02 | |||
| 2020-12-31 | $8.70M 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $32.90M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $13.30M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $8.50M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.30M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $800.00K 10-Q · filed 2016-10-28 | |||
| 2015-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $7.10M 10-K · filed 2018-02-28 | ||
| 2015-09-30 | $6.50M 10-Q · filed 2016-10-28 | |||
| 2014-12-31 | $1.00M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $3.50M 8-K · filed 2017-09-19 | ||
| 2014-09-30 | $2.50M 10-Q · filed 2015-10-29 | |||
| 2013-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.80M derived: sum of 2 quarters · filed 2016-02-25 | $9.20M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $8.10M 10-Q · filed 2014-10-28 | ||
| 2013-06-30 | $5.40M 10-Q · filed 2013-07-30 | |||
| 2012-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $4.70M derived: sum of 2 quarters · filed 2015-03-02 | $8.90M derived: sum of 3 quarters · filed 2015-03-02 | $9.10M 10-K · filed 2015-03-02 |
| 2012-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $8.40M derived: sum of 2 quarters · filed 2013-10-29 | $8.60M 10-Q · filed 2013-10-29 | $9.00M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-30 | $4.40M 10-Q · filed 2013-07-30 | $4.80M derived: sum of 3 quarters · filed 2014-02-20 | $4.90M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $200.00K 10-Q · filed 2012-05-01 | $600.00K derived: sum of 2 quarters · filed 2014-02-20 | $700.00K derived: sum of 3 quarters · filed 2014-02-20 | $1.00M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $500.00K derived: sum of 2 quarters · filed 2014-02-20 | $800.00K derived: sum of 3 quarters · filed 2014-02-20 | $8.40M 10-K · filed 2014-02-20 |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | $400.00K derived: sum of 2 quarters · filed 2012-10-26 | $8.00M 10-Q · filed 2012-10-26 | $8.50M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $7.90M 10-Q · filed 2012-07-27 | $8.40M derived: sum of 3 quarters · filed 2013-02-19 | $20.60M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $7.60M 10-Q · filed 2012-05-01 | $8.10M derived: sum of 2 quarters · filed 2013-02-19 | $20.30M derived: sum of 3 quarters · filed 2013-02-19 | $33.20M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $12.70M derived: sum of 2 quarters · filed 2013-02-19 | $25.60M derived: sum of 3 quarters · filed 2013-02-19 | $26.00M 10-K · filed 2013-02-19 |
| 2010-09-30 | $12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $25.10M derived: sum of 2 quarters · filed 2011-11-04 | $25.50M 10-Q · filed 2011-11-04 | $27.20M derived: sum of 4 quarters · filed 2012-09-06 |
| 2010-06-30 | $12.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $13.30M 10-Q · filed 2011-08-04 | $15.00M derived: sum of 3 quarters · filed 2012-09-06 | $15.50M derived: sum of 4 quarters · filed 2012-09-06 |
| 2010-03-31 | $400.00K 10-Q · filed 2011-05-02 | $2.10M derived: sum of 2 quarters · filed 2012-09-06 | $2.60M derived: sum of 3 quarters · filed 2012-09-06 | |
| 2009-12-31 | $1.70M derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $2.20M derived: sum of 2 quarters · filed 2012-09-06 | $3.80M 8-K · filed 2012-09-06 | |
| 2009-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $2.10M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | $1.60M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $4.80M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |